Board
The Interpharma Board determines the strategic direction of the association and represents the interests of research-based pharmaceutical companies in Switzerland.
Jörg-Michael Rupp 1
President
Director Pharma International – Roche
Julian Bertschinger 1
Vice-President
Head EMEA External Scientific Innovation – Johnson & Johnson
Myriam DeLeone 1
Vice-President
General Manager Switzerland – Amgen
Iris Zemzoum 1, 2
Vice-President
President Region Europe – Novartis
René P. Buholzer
Delegate of the Board
Interpharma
Jérome Garcin
General Manager for Switzerland and Austria – Bristol Myers Squibb
Thorsten Hein
Country Division Head, Pharmaceuticals – Bayer
Bairbre Hickie 1, 2
General Manager Switzerland – Takeda
Rea Lal
Country Lead of Pfizer Switzerland – Pfizer
Annette Luther 2
Head External Affairs Switzerland – Roche
Lauren McNamer
General Manager of Lilly Switzerland – Eli Lilly
Andrea Michael Meyer
Head Global Supply Chain Strategy & Excellence/VP – Sanofi
Michele Ravara
Managing Director for Switzerland – AbbVie
Florian Saur
Country President Switzerland – AstraZeneca
Patrick Schuler 2
Managing Director – Johnson & Johnson Innovative Medicine
David Traub
Managing Director Pharma Switzerland – Novartis
Anne Mette Wiis Vogelsang 2
CVP and General Manager Switzerland – Novo Nordisk
Legend:
1 Member of the Nomination and Membership Committee
2 Member of the Finance Board Committee